APA

Loftus B., Newsom B., Montgomery M., Von Gynz-Rekowski K., Riser M., Inman S., Garces P., Rill D., Zhang J. & Williams J. C. (20090515). Autologous attenuated T-cell vaccine (Tovaxin) dose escalation in multiple sclerosis relapsing-remitting and secondary progressive patients nonresponsive to approved immunomodulatory therapies. : Clinical immunology (Orlando, Fla.).

Chicago

Loftus B, Newsom B, Montgomery M, Von Gynz-Rekowski K, Riser M, Inman S, Garces P, Rill D, Zhang J and Williams J C. 20090515. Autologous attenuated T-cell vaccine (Tovaxin) dose escalation in multiple sclerosis relapsing-remitting and secondary progressive patients nonresponsive to approved immunomodulatory therapies. : Clinical immunology (Orlando, Fla.).

Harvard

Loftus B., Newsom B., Montgomery M., Von Gynz-Rekowski K., Riser M., Inman S., Garces P., Rill D., Zhang J. and Williams J. C. (20090515). Autologous attenuated T-cell vaccine (Tovaxin) dose escalation in multiple sclerosis relapsing-remitting and secondary progressive patients nonresponsive to approved immunomodulatory therapies. : Clinical immunology (Orlando, Fla.).

MLA

Loftus B, Newsom B, Montgomery M, Von Gynz-Rekowski K, Riser M, Inman S, Garces P, Rill D, Zhang J and Williams J C. Autologous attenuated T-cell vaccine (Tovaxin) dose escalation in multiple sclerosis relapsing-remitting and secondary progressive patients nonresponsive to approved immunomodulatory therapies. : Clinical immunology (Orlando, Fla.). 20090515.